New Glasgow Cancer Tests for Research and Clinical Trials

Published: 5 November 2019

The Glasgow Precision Oncology Laboratory (GPOL) at the University of Glasgow has developed a ground-breaking new cancer test for research and clinical trials that could ultimately change the way cancer medicine is delivered.

The Glasgow Cancer Tests are a suite of affordable solid tumour and blood cancer tests, developed specifically to enable patients to benefit from real-world precision medicine-based cancer treatments.

The Glasgow Cancer Tests are designed to be used in routine healthcare, such as the NHS, around the world, to enable doctors to offer the latest treatments and trials to cancer patients. These tests will also help scientists discover what makes cancer resistant to chemotherapy drugs, as well as provide data that will aid the development of new treatments.

The Glasgow Cancer Tests are currently being evaluated by NHS labs in England and Scotland. The tests are also being used in the University of Glasgow-led Precision-Panc clinical trials programme for patients with pancreatic cancer.

Read More

First published: 5 November 2019

<< News